tiprankstipranks
Trending News
More News >

NextGen Healthcare price target raised to $23.95 from $18 at Truist

Truist raised the firm’s price target on NextGen Healthcare to $23.95 from $18 and keeps a Hold rating on the shares. The analyst states that the price target increase reflects the latest deal price for the company after the announcement that it is being acquired by Thoma Bravo at $23.95 per share.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on NXGN:

Disclaimer & DisclosureReport an Issue